Chargement des cours...
Prévisions
L'objectif de cours moyen des analystes est de 81,09 € (-10,15 %). La médiane est de 81,09 € (-10,15 %).
| Acheter |
10 |
| Conserver |
3 |
| Vendre |
0 |
Discussions dans la communauté
Il n'y a pas encore de discussion sur cet actif.
Lancer une discussionActualités Accéder au fil d'actualités
U.S. Physical Therapy expands hospital alliances with NYU Langone to boost visits and reimbursement
U.S. Physical Therapy is pursuing growth through clinic openings, acquisitions and hospital alliances, highlighted by a 10-year NYU Langone partnership that added 60 New York locations and yields flat per-visit payments with higher, more predictable reimbursement. The company opens about 25–30 clinics organically and acquires 30–70 annually using a local-partnership model that preserves clinician ownership and brands. Its injury-prevention unit has grown to roughly $120 million in revenue and more than $20 million in EBITDA, delivering margins about twice those of the physical therapy segment. Management reports about $220 million in debt, expects EBITDA above $100 million for the year, and has capital available for further expansion and share repurchases. » Plus sur finance.yahoo.com
U.S. Physical Therapy relies on partnerships and Briotix to offset Medicare pressure
U.S. Physical Therapy pursues a growth strategy based on a partnership model, hospital alliances (including an exclusive deal with NYU Langone) and expansion of its Briotix division to compensate for lower Medicare reimbursements and competition in the outpatient market. The NYU partnership is expected to bring about 700,000 additional treatments per year long term; Briotix generates roughly $120 million in revenue with substantially higher margins than the physical therapy business. Management views debt of about $220 million and expected EBITDA above $100 million as a manageable framework; it anticipates recoveries in Medicare reimbursement from 2024/2025 and stronger increases from 2028. » Plus sur de.investing.com
Nchacha Etta to become CFO of U.S. Physical Therapy
U.S. Physical Therapy appoints Nchacha Etta effective September 1, 2026, as executive vice president and chief financial officer. Etta previously served as CFO at Omnicell and held financial leadership roles at Essilor of America, Johnson & Johnson Vision and Coca‑Cola; he also sits on the board of directors of KBR. Jason Curtis will remain senior vice president for finance and accounting and will return to that role after serving as interim CFO. U.S. Physical Therapy operates 796 outpatient physical therapy clinics in 45 U.S. states. » Plus sur de.investing.com
U.S. Physical Therapy expands into new U.S. state through acquisition
U.S. Physical Therapy has acquired a physiotherapy group with 12 clinics, taking a 67% stake in the company while the previous owners retain 33%. The acquired group delivers about 112,000 treatments per year and generates annual revenue of USD 12 million. With the purchase, U.S. Physical Therapy increases its presence from 44 to 45 states and now operates 795 outpatient clinics; trailing twelve‑month revenue is USD 788 million. » Plus sur de.investing.com
U.S. Physical Therapy misses Q1 2026 forecasts, stock falls
U.S. Physical Therapy reported a GAAP loss per share of $0.12 for Q1 2026, missing the expected $0.54 by a wide margin; revenue was $198 million (expectation $200.26 million), a year‑over‑year increase of 7.9%. Weather‑related cancellations of roughly 31,000 patient appointments are estimated to have reduced revenue by about $3.3 million. The stock fell roughly 2% in after‑hours trading; management plans to push efficiency measures, virtualize reception areas, implement AI‑assisted documentation, and expand self‑pay offerings. » Plus sur de.investing.com
Dividendes historiques Dividendes
Tous les indicateurs de dividendes Tous les indicateursDonnées financières de l'entreprise
| (EUR) | septembre 2026 | YoY |
|---|---|---|
| Chiffre d'affaires | 196,49 M | 40,58 % |
| Bénéfice brut | 37,99 M | 20,91 % |
| Bénéfice net | 9,75 M | 57,99 % |
| EBITDA | 27,71 M | 4,52 % |
Données fondamentales
| Indicateur | Valeur |
|---|---|
Capitalisation boursière | 1,33 Md € |
Nombre d'actions | 14,93 M |
Plus haut/bas sur 52 semaines | 91,16 € - 52,43 € |
Rendement du dividende | 1,74 % |
Dividendes TTM | 1,57 € |
Prochain dividende | 0,41 € |
Bêta | 1,13 |
Ratio P/E | -73,51 |
Ratio PEG | 0,47 |
Ratio P/B | 3,45 |
Ratio P/S | 1,77 |
Profil de l'entreprise
U.S. Physical Therapy, Inc., par l'intermédiaire de ses filiales, exploite des cliniques de kinésithérapie ambulatoire qui assurent les soins pré- et post-opératoires et le traitement des troubles orthopédiques, des blessures liées au sport, des soins préventifs, la rééducation des travailleurs blessés et des lésions d'origine neurologique. Elle opère à travers deux segments, Physical Therapy Operations et Industrial Injury Prevention Services. La société propose des services de prévention des accidents du travail, notamment la prévention et la rééducation sur site, l'optimisation des performances, les tests d'aptitude à l'emploi après offre d'embauche, les évaluations de la capacité fonctionnelle et les évaluations ergonomiques, assurés par des kinésithérapeutes et des entraîneurs sportifs certifiés spécialisés, auprès de sociétés figurant au Fortune 500 et d'autres clients, notamment des assureurs et leurs sous-traitants. Au 31 décembre 2021, elle exploitait 591 cliniques dans 39 États et gérait 35 cabinets de kinésithérapie. La société a été fondée en 1990 et son siège se trouve à Houston, au Texas.
| Nom | U.S. Physical Therapy |
| PDG | Christopher J. Reading |
| Siège social | Houston,
tx États-Unis |
| Site web | |
| Secteur | Santé |
| Industrie | Prestataires et services de santé |
| Introduction en bourse | 29/05/1992 |
| Employés | 6 374 |
Symboles boursiers
| Bourse | Symbole |
|---|---|
NYSE | USPH |
Frankfurt | UPH.F |
Düsseldorf | UPH.DU |